Page last updated: 2024-12-04

alpha-aceto-alpha-hydroxybutyrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-aceto-alpha-hydroxybutyrate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21
CHEBI ID982
SCHEMBL ID42929
MeSH IDM0089914

Synonyms (24)

Synonym
acetohydroxybutyric acid
butanoic acid, 2-ethyl-2-hydroxy-3-oxo- (9ci)
alpha-aceto-alpha-hydroxybutyrate
2-aceto-2-hydroxybutyrate
butanoic acid, 2-ethyl-2-hydroxy-3-oxo
aaahb
2-aceto-2-hydroxybutyric acid
alpha-acetohydroxybutyric acid
acetoacetic acid, 2-ethyl-2-hydroxy- (6ci,7ci,8ci)
butanoic acid, 2-ethyl-2-hydroxy-3-oxo-, (2s)-
acetohydroxybutyrate
C00659
3142-65-2
2-aceto-2-hydroxybutanoate
AKOS006380539
butanoic acid, 2-ethyl-2-hydroxy-3-oxo-
2-ethyl-2-hydroxy-3-oxobutanoic acid
SCHEMBL42929
CHEBI:982
LMFA01050501
2-ethyl-2-hydroxy-3-oxo-butanoic acid
2-hydroxy-2-ethyl-3-keto-butanoic acid
Q27105388
2-ethyl-2-hydroxy-3-oxobutanoicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxy fatty acidAny fatty acid carrying one or more hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (58.82)18.7374
1990's2 (11.76)18.2507
2000's1 (5.88)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]